Major tuberculosis vaccine trial completes enrollment faster than expected

**Tuberculosis Vaccine Trial Reaches Enrollment Target Ahead of Schedule**

A clinical trial evaluating a potential new tuberculosis vaccine has successfully completed its participant enrollment earlier than anticipated. The study, which aims to test what could become the first new tuberculosis vaccine in over 100 years, reached its recruitment goal ahead of schedule, according to recent updates.

The trial is closely monitored due to the global health implications of tuberculosis, a disease that remains one of the leading causes of death worldwide. Researchers have been working to develop more effective preventive measures against the illness, as current vaccines are limited in their efficacy. The accelerated enrollment reflects significant interest and participation in the study, which seeks to address a critical gap in public health efforts against tuberculosis. Further details about the timeline for subsequent phases or results from this trial have not yet been disclosed.

Newsflash | Powered by GeneOnline AI

Source: https://www.statnews.com/2025/04/28/major-tuberculosis-vaccine-trial-completes-enrollment-faster-than-expected/?utm_campaign=rss

Related posts:

STAT+: Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet Hyperglycemia Common in HR+ Breast Cancer Patients Treated with PI3K and AKT Inhibitors Computational analysis clarifies cancer risk for families with genetic variants New Patient Treatment Guidelines to Introduce Sequencing Flexibility and Revised Febrile Neutropenia Risk Assessments on April 30, 2025

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後